The North America AI In Cancer Diagnostics Market would witness market growth of 27.8% CAGR during the forecast period (2022-2028).
The complete and updated MRI-guided biopsies designed by the NCI scientists are now accessible in the clinic and hospitals which don’t require the need of cancer-specific professionals due to this AI tool. The new AI-featured algorithms have overpassed the abilities of professional radiologists by allowing the forecast of patient reports utilizing MRI. However, advanced AI methods can be employed to discover the gene mutations from tumor pathology images rather than utilizing standard genomic sequencing.
For example, scientists at New York University backed by the NCI utilized the deep learning technique to discover pathology images of lung tumors received from the Cancer Genome Atlas. Deep learning techniques can also be utilized to distinguish and detect Adenocarcinoma and squamous cell carcinoma which are the most prevalent lung cancer subtypes along with the identification of the altered genes from the images.
In collaboration with the Department of Energy (DOE), the Cancer Moonshot is assisting two crucial efforts to utilize its supercomputing expertise and capacity for cancer research and development. Moreover, Artificial intelligence is utilized to analyze and explain characteristics of the targeted molecules such as nucleic or protein acids that are crucial for the evolution of cancer also AI helps to predict new medication for targeted molecules and assets evaluating the efficacy of the medication.
Cancer is one of the foremost causes of mortality in the United States. The early-stage diagnosis of cancer is still a complicated procedure in most healthcare facilities. Due to the growing government actions and growing recession along with the enhancement in the healthcare industry. There were 863,830 female cases and 888,905 male cases of new invasive cancer recorded in the United States in 2019. The incidence rate for all cancers combined was 439 per 100,000 people in the general population.
The US market dominated the North America AI In Cancer Diagnostics Market by Country in 2021; thereby, achieving a market value of $146.7 million by 2028. The Canada market is experiencing a CAGR of 30.7% during (2022 - 2028). Additionally, The Mexico market would exhibit a CAGR of 29.6% during (2022 - 2028).
Based on End-user, the market is segmented into Hospital, Surgical Centers & Medical Institutes and Others. Based on Component, the market is segmented into Software Solutions, Hardware and Services. Based on Cancer Type, the market is segmented into Breast Cancer, Lung Cancer, Brain Tumor, Skin Cancer & Cervical Cancer, Prostate & Colorectal Cancer and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global AI In Cancer Diagnostics Market is Estimated to reach $509 Million by 2028, at a CAGR of 28.6%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Microsoft Corporation, Flatiron Health, Paige AI, Inc., PathAI, Inc., Therapixel, Tempus, Inc., SkinVision BV, Cancer Center Sp. z o.o., Medial EarlySign and Kheiron Medical Technologies Limited.
Scope of the Study
Market Segments Covered in the Report:
By End-user
- Hospital
- Surgical Centers & Medical Institutes
- Others
By Component
- Software Solutions
- Hardware
- Services
By Cancer Type
- Breast Cancer
- Lung Cancer
- Brain Tumor
- Skin Cancer & Cervical Cancer
- Prostate & Colorectal Cancer
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Microsoft Corporation
- Flatiron Health
- Paige AI, Inc.
- PathAI, Inc.
- Therapixel
- Tempus, Inc.
- SkinVision BV
- Cancer Center Sp. z o.o.
- Medial EarlySign
- Kheiron Medical Technologies Limited
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America AI In Cancer Diagnostics Market, by End-user
1.4.2 North America AI In Cancer Diagnostics Market, by Component
1.4.3 North America AI In Cancer Diagnostics Market, by Cancer Type
1.4.4 North America AI In Cancer Diagnostics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenarios
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2019, Dec – 2022, Nov) Leading Players
Chapter 4. North America AI In Cancer Diagnostics Market by End-user
4.1 North America Hospital Market by Country
4.2 North America Surgical Centers & Medical Institutes Market by Country
4.3 North America Others Market by Country
Chapter 5. North America AI In Cancer Diagnostics Market by Component
5.1 North America Software Solutions Market by Country
5.2 North America Hardware Market by Country
5.3 North America Services Market by Country
Chapter 6. North America AI In Cancer Diagnostics Market by Cancer Type
6.1 North America Breast Cancer Market by Country
6.2 North America Lung Cancer Market by Country
6.3 North America Brain Tumor Market by Country
6.4 North America Skin Cancer & Cervical Cancer Market by Country
6.5 North America Prostate & Colorectal Cancer Market by Country
6.6 North America Others Market by Country
Chapter 7. North America AI In Cancer Diagnostics Market by Country
7.1 US AI In Cancer Diagnostics Market
7.1.1 US AI In Cancer Diagnostics Market by End-user
7.1.2 US AI In Cancer Diagnostics Market by Component
7.1.3 US AI In Cancer Diagnostics Market by Cancer Type
7.2 Canada AI In Cancer Diagnostics Market
7.2.1 Canada AI In Cancer Diagnostics Market by End-user
7.2.2 Canada AI In Cancer Diagnostics Market by Component
7.2.3 Canada AI In Cancer Diagnostics Market by Cancer Type
7.3 Mexico AI In Cancer Diagnostics Market
7.3.1 Mexico AI In Cancer Diagnostics Market by End-user
7.3.2 Mexico AI In Cancer Diagnostics Market by Component
7.3.3 Mexico AI In Cancer Diagnostics Market by Cancer Type
7.4 Rest of North America AI In Cancer Diagnostics Market
7.4.1 Rest of North America AI In Cancer Diagnostics Market by End-user
7.4.2 Rest of North America AI In Cancer Diagnostics Market by Component
7.4.3 Rest of North America AI In Cancer Diagnostics Market by Cancer Type
Chapter 8. Company Profiles
8.1 Microsoft Corporation
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 SWOT Analysis
8.2 Flatiron Health (F. Hoffmann-La Roche Ltd.)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.3 Paige AI, Inc.
8.3.1 Company Overview
8.3.2 Recent strategies and developments:
8.3.2.1 Partnerships, Collaborations, and Agreements:
8.3.2.2 Product Launches and Product Expansions:
8.4 PathAI, Inc.
8.4.1 Company Overview
8.4.2 Recent strategies and developments:
8.4.2.1 Partnerships, Collaborations, and Agreements:
8.4.2.2 Acquisition and Mergers:
8.5 Therapixel
8.5.1 Company Overview
8.5.2 Recent strategies and developments:
8.5.2.1 Product Launches and Product Expansions:
8.6 Tempus, Inc.
8.6.1 Company Overview
8.6.2 Recent strategies and developments:
8.6.2.1 Partnerships, Collaborations, and Agreements:
8.7 SkinVision BV
8.7.1 Company Overview
8.8 Cancer Center Sp. z o.o.
8.8.1 Company Overview
8.9 Medial EarlySign
8.9.1 Company Overview
8.10. Kheiron Medical Technologies Limited
8.10.1 Company Overview
8.10.2 Recent strategies and developments:
8.10.2.1 Partnerships, Collaborations, and Agreements:
TABLE 1 North America AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
TABLE 2 North America AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
TABLE 3 Partnerships, Collaborations and Agreements– AI In Cancer Diagnostics Market
TABLE 4 Product Launches And Product Expansions– AI In Cancer Diagnostics Market
TABLE 5 Acquisition and Mergers– AI In Cancer Diagnostics Market
TABLE 6 North America AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
TABLE 7 North America AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
TABLE 8 North America Hospital Market by Country, 2018 - 2021, USD Thousands
TABLE 9 North America Hospital Market by Country, 2022 - 2028, USD Thousands
TABLE 10 North America Surgical Centers & Medical Institutes Market by Country, 2018 - 2021, USD Thousands
TABLE 11 North America Surgical Centers & Medical Institutes Market by Country, 2022 - 2028, USD Thousands
TABLE 12 North America Others Market by Country, 2018 - 2021, USD Thousands
TABLE 13 North America Others Market by Country, 2022 - 2028, USD Thousands
TABLE 14 North America AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
TABLE 15 North America AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
TABLE 16 North America Software Solutions Market by Country, 2018 - 2021, USD Thousands
TABLE 17 North America Software Solutions Market by Country, 2022 - 2028, USD Thousands
TABLE 18 North America Hardware Market by Country, 2018 - 2021, USD Thousands
TABLE 19 North America Hardware Market by Country, 2022 - 2028, USD Thousands
TABLE 20 North America Services Market by Country, 2018 - 2021, USD Thousands
TABLE 21 North America Services Market by Country, 2022 - 2028, USD Thousands
TABLE 22 North America AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
TABLE 23 North America AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
TABLE 24 North America Breast Cancer Market by Country, 2018 - 2021, USD Thousands
TABLE 25 North America Breast Cancer Market by Country, 2022 - 2028, USD Thousands
TABLE 26 North America Lung Cancer Market by Country, 2018 - 2021, USD Thousands
TABLE 27 North America Lung Cancer Market by Country, 2022 - 2028, USD Thousands
TABLE 28 North America Brain Tumor Market by Country, 2018 - 2021, USD Thousands
TABLE 29 North America Brain Tumor Market by Country, 2022 - 2028, USD Thousands
TABLE 30 North America Skin Cancer & Cervical Cancer Market by Country, 2018 - 2021, USD Thousands
TABLE 31 North America Skin Cancer & Cervical Cancer Market by Country, 2022 - 2028, USD Thousands
TABLE 32 North America Prostate & Colorectal Cancer Market by Country, 2018 - 2021, USD Thousands
TABLE 33 North America Prostate & Colorectal Cancer Market by Country, 2022 - 2028, USD Thousands
TABLE 34 North America Others Market by Country, 2018 - 2021, USD Thousands
TABLE 35 North America Others Market by Country, 2022 - 2028, USD Thousands
TABLE 36 North America AI In Cancer Diagnostics Market by Country, 2018 - 2021, USD Thousands
TABLE 37 North America AI In Cancer Diagnostics Market by Country, 2022 - 2028, USD Thousands
TABLE 38 US AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
TABLE 39 US AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
TABLE 40 US AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
TABLE 41 US AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
TABLE 42 US AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
TABLE 43 US AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
TABLE 44 US AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
TABLE 45 US AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
TABLE 46 Canada AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
TABLE 47 Canada AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
TABLE 48 Canada AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
TABLE 49 Canada AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
TABLE 50 Canada AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
TABLE 51 Canada AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
TABLE 52 Canada AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
TABLE 53 Canada AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
TABLE 54 Mexico AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
TABLE 55 Mexico AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
TABLE 56 Mexico AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
TABLE 57 Mexico AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
TABLE 58 Mexico AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
TABLE 59 Mexico AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
TABLE 60 Mexico AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
TABLE 61 Mexico AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
TABLE 62 Rest of North America AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
TABLE 63 Rest of North America AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
TABLE 64 Rest of North America AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
TABLE 65 Rest of North America AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
TABLE 66 Rest of North America AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
TABLE 67 Rest of North America AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
TABLE 68 Rest of North America AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
TABLE 69 Rest of North America AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
TABLE 70 key information – Microsoft Corporation
TABLE 71 Key Information – Flatiron Health
TABLE 72 Key Information –Paige AI, Inc.
TABLE 73 Key Information – PathAI, Inc.
TABLE 74 Key Information –Therapixel
TABLE 75 Key Information – Tempus, Inc.
TABLE 76 Key Information – SkinVision BV
TABLE 77 Key Information – Cancer Center Sp. z o.o.
TABLE 78 Key Information – Medial EarlySign
TABLE 79 Key Information – Kheiron Medical Technologies Limited
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2019, Dec – 2022, Nov) Leading Players
FIG 5 SWOT Analysis: Microsoft Corporation
FIG 6 Recent strategies and developments: Paige AI, Inc.
FIG 7 Recent strategies and developments: PathAI, Inc.